Is Skyrizi Copay Assistance a Joke for Psoriasis Patients Without Full Insurance Coverage?
Quick Answer No, Skyrizi Copay Assistance is not a joke, but its significant limitations can render it ineffective for many psoriasis patients, particularly those without robust insurance coverage. The program is designed to work with commercial insurance and primarily covers the patient's copay or coinsurance, not the full cost of the drug if insurance denies coverage or if the patient is uninsured. The critical exception is that assistance caps out at a maximum annual amount, after which patients are responsible for the full cost, which can be financially devastating. Key Takeaways Skyrizi Copay Assistance requires active commercial insurance and will not cover the drug's full list price if your claim is denied. The program has a maximum annual benefit limit (often $20,000), leaving patients fully exposed to costs once that cap is reached. Patients on government plans like Medicare, Medicaid, or TriCare are legally prohibited from using manufacturer copay ...